Previous
Next
Days
Hours
Minutes
Seconds

THE 29th ANNUAL SCIENTIFIC MEETING OF INDONESIAN HEART ASSOCIATION

RITZ CARLTON HOTEL, JAKARTA 

JUNE 18 – 21, 2020

Guidelines for Abstract Submission

The 29th ASMIHA Committee invites you to submit your research works for consideration to be published (in abstract form) in European Heart Journal Supplement. Abstract should constitute of original research (epidemiological studies, clinical studies, basic-translational studies and animal studies are equally encouraged) in the cardiovascular fields. The content may include portions of prior abstracts and/or manuscripts submitted or presented elsewhere.
Submission of an abstract constitutes a commitment by the author(s) to present, if accepted. Failure to register and present may jeopardize future acceptance of abstracts. Please write the abstract following the guidance below. Abstract with different format will not be reviewed.

Abstract Submission Guidelines

  • Abstract Title
    • Abstract titles should be concise and should not contain abbreviations. Please use correct Title Case and make sure to bold the entire title.
    • Example:

This is a Properly Formatted Title

  • Abstract Author(s)
    • All individuals listed as authors should qualify for authorship and should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Authors included in the manuscript should meet the following conditions:
      1. Substantial contributions to the conception and design, acquisition of data, or analysis and interpretation of data
      2. Drafting the article or revising it critically for important intellectual content and
      3. Final approval of the version to be published. Any other contributors to the work who do not qualify for authorship should be listed in an acknowledgement section.
    • The submitting author is automatically designed as the primary/presenting author. List of author(s), institution(s), city, and country should be written immediately below the title. Institute(s), city, and country should be written in Italic and Authors name should be listed by initials followed by family name only. First author name should be underlined.
    • Example:
      E. J.  Topol1,  P. Libby2, E. Braunwald2,1Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; 2NationalCardiovascular Center Harapan Kita, Jakarta, Indonesia
  • Abstract Text
    • Abstract must be submitted in English.
    • Use Times New Roman for the text font and Symbol for the Greek and special characters.
    • The numbers of words should not exceed 300 without titles, authors, and
    • The abstract should be formatted with the following headings:
      1. Aims or Background,
      2. Methods,
      3. Results,
      4. Conclusion,
      5. Keywords. A maximum of six keywords may be submitted.
    • Supported file formats are MS Word and Word Document (.doc or .docx),
      other file formats will not be processed.
    • Figures and images must be uploaded separately. Supported file format is
      JPG or JPEG. The maximum numbers figures and/or images submitted are 2
      for each abstract.
    • Use zeros before decimal points, use dot (.) for marking decimal points, use
      lower case “p” values. Example p<0.05.
    • Provide manufacturer name and location in parentheses for all brand or
      trade names. For brand drugs, include generic names in parentheses.
    • Do not include references, credits, or grant support.
  • Abstract Policies and Procedures
    • There is no submission fee required to submit an abstract to The 29th ASMIHA.
    • Registration to the main symposium is a must for all accepted abstracts.
    • Abstract must be submitted electronically ONLY through our website at asmiha.org by 11.00 p.m WIB, on Wednesday, April 1, 2020.
    • Abstract submitters will get an email confirmation of notification.
    • There is no limit to the number of abstracts a person may submit.
    • Incomplete submissions cannot be processed.
    • All abstract submitted are disclosure to members of the Peer Review Selection Committee.
    • Abstract grading is blinded and abstracts are selected on the basis of merit.
    • Submitters may revise information, correct typographical errors, tables graphics, or withdraw an abstract any time before 11:59 p.m. WIB on Wednesday, April 1, 2020. Please contact scientific@inaheart.org to revise or withdraw an abstract.
    • The 29th ASMIHA committee is unable to reimburse abstract submitters for travel, hotel, and per diem expenses.
  • Recognition
    • Accepted abstracts will be available at The 29th ASMIHA Program Book.
    • Accepted abstracts will be published at European Heart Journal Supplement.
  • Case Report should be presented in sections – namely:
    • Title of The Article
    • Abstract (in English)
    • No more than 300 words, summarising the case that is being discussed. Abstracts will have to be written using structured form using the following format
      • Background
      • Case illustration and discussion
      • Conclusion
      • Put keywords after abstract.
        Keywords should not exceed five items.
Secretariat

Indonesian Heart Association
Heart House PERKI
Jl. Katalia Raya No. 5
Kota Bambu Utara, Palmerah, Jakarta Barat
Phone : (021) 5681149 Ext : 101 – 104
Fax : (021) 5684220
E-mail : secretariat@inaheart.org
              scientific@inaheart.org

General Registration
Phone : (021) 5681149 Ext 101 – 104
Fax : (021) 5684220
E-mail : registration@asmiha.org

Payment Registration
Bank Mandiri KK Harapan Kita, Slipi, Jakarta
A/C Number : 117 000 777 8822
Acc. Name : PP PERKI.ASMIHA

Close Menu